CROTTI, LIA
 Distribuzione geografica
Continente #
NA - Nord America 10.446
EU - Europa 4.265
AS - Asia 1.599
SA - Sud America 59
OC - Oceania 27
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 7
Totale 16.418
Nazione #
US - Stati Uniti d'America 10.322
IT - Italia 1.051
CN - Cina 911
IE - Irlanda 864
SE - Svezia 686
DE - Germania 508
HK - Hong Kong 445
GB - Regno Unito 320
UA - Ucraina 197
RU - Federazione Russa 125
CA - Canada 115
FR - Francia 101
ES - Italia 66
NL - Olanda 53
DK - Danimarca 50
VN - Vietnam 49
AT - Austria 48
IN - India 48
FI - Finlandia 46
JP - Giappone 45
BE - Belgio 36
BR - Brasile 26
CH - Svizzera 23
SG - Singapore 22
GR - Grecia 21
AU - Australia 19
TR - Turchia 17
PT - Portogallo 16
PL - Polonia 12
RO - Romania 12
AR - Argentina 10
CL - Cile 10
CO - Colombia 9
MX - Messico 8
NZ - Nuova Zelanda 8
SC - Seychelles 7
RS - Serbia 6
IR - Iran 5
KW - Kuwait 5
KZ - Kazakistan 5
MY - Malesia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AE - Emirati Arabi Uniti 4
BD - Bangladesh 4
CZ - Repubblica Ceca 4
IL - Israele 4
KR - Corea 4
NO - Norvegia 4
TH - Thailandia 4
BG - Bulgaria 3
CY - Cipro 3
EU - Europa 3
HR - Croazia 3
LK - Sri Lanka 3
SA - Arabia Saudita 3
TW - Taiwan 3
BY - Bielorussia 2
EG - Egitto 2
ET - Etiopia 2
LT - Lituania 2
MT - Malta 2
OM - Oman 2
PY - Paraguay 2
SI - Slovenia 2
AM - Armenia 1
BO - Bolivia 1
HU - Ungheria 1
ID - Indonesia 1
IQ - Iraq 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MD - Moldavia 1
MN - Mongolia 1
MU - Mauritius 1
NG - Nigeria 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
ZA - Sudafrica 1
Totale 16.418
Città #
Fairfield 1.558
Ann Arbor 1.273
Dublin 812
Chandler 740
Woodbridge 698
Ashburn 693
Wilmington 674
Houston 595
Seattle 563
Dearborn 501
Cambridge 491
Hong Kong 428
Frankfurt am Main 420
New York 418
Princeton 363
Milan 326
Lawrence 161
Nanjing 161
Jacksonville 153
Altamura 152
San Diego 103
Beijing 96
London 69
Shenyang 61
Hebei 60
Andover 57
Guangzhou 56
Nanchang 55
Toronto 54
Jinan 50
Vienna 47
Rome 44
Shanghai 39
Helsinki 36
Zhengzhou 36
Dong Ket 35
Boardman 33
Jiaxing 32
Tianjin 31
Changsha 28
Norwalk 28
Ottawa 26
Phoenix 26
Hangzhou 22
Ningbo 22
Chicago 19
São Paulo 19
Tokyo 18
Brussels 17
Castano Primo 17
Hefei 17
Amsterdam 13
Groningen 13
Kunming 13
San Francisco 13
Upper Marlboro 13
Central 12
Los Angeles 12
Pavia 12
Pune 12
Clearwater 11
Edmonton 11
Madrid 11
Falls Church 10
Huizen 10
Redmond 10
Voghera 10
Washington 10
Athens 9
Moscow 9
Mountain View 9
Taizhou 9
Wuhan 9
Fremont 8
Turin 8
Zurich 8
Atlanta 7
Cincinnati 7
Copenhagen 7
Kilburn 7
Liège 7
Alicante 6
Desio 6
Esplugues de Llobregat 6
Fuzhou 6
Girona 6
Kiev 6
Lambeth 6
Lappeenranta 6
Naples 6
Paris 6
Porto 6
Rennes 6
San Mateo 6
Saronno 6
Torino 6
Bari 5
Bogotá 5
Brescia 5
Buenos Aires 5
Totale 12.843
Nome #
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 334
Calmodulinopathy: A Novel, Life-Threatening Clinical Entity Affecting the Young 309
Indications and utility of cardiac genetic testing in athletes 277
International Triadin Knockout Syndrome Registry: The Clinical Phenotype and Treatment Outcomes of Patients with Triadin Knockout Syndrome 263
NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis 257
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 245
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 229
Calmodulinopathy: Functional Effects of CALM Mutations and Their Relationship With Clinical Phenotypes 222
Pulmonary hypertension due to a stiff left atrium: Speckle tracking equivalents of large V-waves 197
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy 182
Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation 179
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 179
The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitability 175
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome 172
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 165
Partial Pericardial Agenesis Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy 144
Investigation on Sudden Unexpected Death in the Young (SUDY) in Europe: results of the European Heart Rhythm Association Survey 133
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 128
Infanticide vs. inherited cardiac arrhythmias. 128
Response by Crotti et al to Letter Regarding Article, "genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1?" 127
Biventricular arrhythmogenic cardiomyopathy: a paradigmatic case. 126
Inherited cardiac arrhythmia syndrome. Role of potassium channels 124
Long QT Syndrome and Brugada Syndrome : 2 aspects of the same disease? 123
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents 121
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 120
The ICD for the long QT syndrome: which indications, complications, and results? 119
Brugada and Long QT Syndrome are two different diseases: True or False? 119
Exercise Training-Induced Repolarization Abnormalities Masquerading as Congenital Long QT Syndrome 119
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 118
Mapping the human genetic architecture of COVID-19 118
Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1? 117
Condizioni cliniche associate ad anomalie dell'intervallo QT: Implicazioni cliniche [Clinical conditions associated with abnormal QT interval: clinical implications] 116
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls 113
Long and Short QT syndromes. 112
Does pregnancy increase cardiac risk for LQT1 patients with the KCNQ1-A341V mutation? 111
Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2 Long QT Syndrome. 111
AKAP9 is a genetic modifier of congenital long-QT syndrome type 1 108
Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families 107
Calmodulin mutations and life-threatening cardiac arrhythmias: Insights from the International Calmodulinopathy Registry 107
A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK) 107
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1 105
Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients 105
Cardiac potassium channel dysfunction in sudden infant death syndrome 105
The genetics underlying acquired long QT syndrome: Impact for genetic screening 103
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population 103
The Common Long QT Syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification 102
The role of genetics in primary ventricular fibrillation, inherited channelopathies and cardiomyopathies 101
The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge 101
Neuroimmune crosstalk in the pathophysiology of hypertension. 101
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome 101
Response to Letters Regarding Article, "clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation" 100
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome 100
The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome 100
Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms 99
Mutation-Specific Risk in Two Genetic Forms of Type 3 Long QT Syndrome 99
Prevalence of the congenital long-qt syndrome 99
Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies 99
To be, or not to be engaged in sport activities, that is the amletic question for patients with coronary artery disease 99
A comprehensive electrocardiographic, molecular, and echocardiographic study of Brugada syndrome: Validation of the 2013 diagnostic criteria 98
Founder populations with channelopathies and church records reveal all sorts of interesting secrets: Some are scientifically relevant 98
Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation 98
Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1 98
Cardiac sodium channel dysfunction in sudden infant death syndrome 97
The genetics underlying idiopathic ventricular fibrillation: A special role for catecholaminergic polymorphic ventricular tachycardia? 97
Long and Short QT Syndromes 97
Gain of function mutation, S422L, in the KCNJ8-encoded cardiac K ATP channel Kir6.1 as a pathogenic substrate for J wave syndromes 96
Congenital long QT syndrome 96
Time, frequency and information domain analysis of heart period and QT variability in asymptomatic long QT syndrome type 2 patients 95
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome 95
Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia 94
Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions -A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of Cardiology 93
An International Multicenter Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition 93
Novel calmodulin mutations associated with congenital long QT syndrome affect calcium current in human cardiomyocytes 92
A refined multiscale self-entropy approach for the assessment of cardiac control complexity: Application to long QT syndrome type 1 patients 92
Sudden cardiac death in infancy: Focus on prolonged repolarization 92
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome 92
SCN5A mutations in 442 neonates and children: genotype-phenotype correlation and identification of higher-risk subgroups. 92
The Long QT Syndrome 92
Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization 91
Impact of clinical and genetic findings on the management of young patients with Brugada syndrome 90
Low-pass filtering approach via empirical mode decomposition improves short scale entropy-based complexity estimation of QT interval variability in Long QT Syndrome Type 1 patients 90
Gene symbol: KCNH2. Disease: Long QT syndrome in Novel human pathological mutations 90
Clinical Implications for Patients With Long QT Syndrome Who Experience a Cardiac Event During Infancy 90
Ion channel diseases in children: Manifestations and management 89
Invasive Hemodynamics of Hypertrophic Cardiomyopathy: Exercise Versus Isoproterenol 89
Genetic of adult and fetal forms of Long QT Syndrome. 88
QTc behavior during exercise and genetic testing for the long-QT syndrome 87
Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel 87
Prevalence of long-QT syndrome gene variants in sudden infant death syndrome 87
Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome 87
When genetic screening for your patient with long QT syndrome comes back negative, don't always take a no for a no 87
All LQT3 patients need an ICD. True or false? 86
The Role of the Cardiac Sodium Channel in Perinatal Early Infant Mortality. 85
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5 84
Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them? Data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry 84
Reply to the Editor--Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients 83
Ion channels and beating heart: the players and the music 83
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death 83
NOS1AP is a genetic modifier of the long-QT syndrome 83
Gene expression and arrhythmic risk 83
Totale 11.986
Categoria #
all - tutte 66.900
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.900


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.079 0 0 0 0 0 0 0 0 0 0 457 622
2019/20203.463 422 148 179 347 318 537 467 342 305 179 136 83
2020/20212.916 68 202 293 297 168 264 543 300 182 231 181 187
2021/20221.909 153 163 235 85 61 117 117 152 95 208 221 302
2022/20233.996 425 913 301 350 274 652 92 261 354 65 169 140
2023/20242.669 124 162 157 89 420 709 509 107 300 92 0 0
Totale 17.553